Cozad Asset Management Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 80.1% during the 2nd quarter, HoldingsChannel reports. The fund owned 4,718 shares of the healthcare conglomerate’s stock after selling 19,037 shares during the period. Cozad Asset Management Inc.’s holdings in UnitedHealth Group were worth $1,472,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in UNH. LFA Lugano Financial Advisors SA purchased a new position in UnitedHealth Group during the second quarter valued at $25,000. Bayforest Capital Ltd raised its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Islay Capital Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter valued at about $31,000. Clal Insurance Enterprises Holdings Ltd lifted its position in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Finally, Glass Jacobson Investment Advisors llc grew its position in UnitedHealth Group by 80.9% during the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 55 shares during the period. 87.86% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on UNH shares. Mizuho boosted their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. TD Cowen increased their price objective on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Sanford C. Bernstein increased their price target on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Finally, Piper Sandler dropped their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.
UnitedHealth Group Trading Up 2.5%
Shares of UNH stock opened at $319.40 on Friday. The stock has a market capitalization of $289.32 billion, a price-to-earnings ratio of 16.67, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The stock’s 50-day moving average price is $344.69 and its 200-day moving average price is $316.39. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the prior year, the firm earned $7.15 EPS. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Where to Find Earnings Call Transcripts
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- There Are Different Types of Stock To Invest In
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Attention Income Investors: This REIT Is on Sale
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
